Short interest in BridgeBio Pharma Inc (NASDAQ:BBIO) increased during the last reporting period, rising from 19.30M to 20.38M. This put 16.56% of the company's publicly available shares short.

Short interest for BridgeBio Pharma gives investors a sense of the degree to which investors are betting on the decline of BridgeBio Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 3.39M shares traded per day, it would take 6.01 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.